CLINICAL_TRIALS
trial_result
· 2025-02-24
Clinical Trial Update: Open-label Extension of the HOPE-2 Trial [Phase 2]
Summary
Open-label extension update for Capricor’s HOPE-2 Phase 2 trial in Duchenne muscular dystrophy, with results posted in February 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Capricor Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-24